Literature DB >> 24670128

Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis.

Arata Nakajima1, Yasuchika Aoki, Yoshifumi Shibata, Masato Sonobe, Fumiaki Terajima, Hiroshi Takahashi, Masahiko Saito, Shinji Taniguchi, Manabu Yamada, Koichi Nakagawa.   

Abstract

OBJECTIVES: Reactive oxygen species (ROS) are considered to be involved in the pathobiology of rheumatoid arthritis (RA); however, their association with disease activity has not been elucidated. In this study, we measured reactive oxygen metabolites (ROM) in patients with RA using a new Free Radical Analytical System and determined clinical parameters associated with ROM.
METHODS: One hundred and fifty-two patients with RA and 80 patients with diabetes mellitus (DM) were included in this observational study. To measure ROM, the d-ROM test was performed on blood samples drawn from all subjects. The correlation between ROM and biomarkers, disease activity, doses of methotrexate (MTX), and prednisolone (PSL) were investigated.
RESULTS: There were significant, positive correlations between ROM and CRP, matrix metalloproteinase 3 (MMP3), Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR), Clinical Disease Activity Index (CDAI), and the Simplified Disease Activity Index (SDAI). Multiple regression analysis revealed that CRP and DAS28-ESR were correlated with ROM.
CONCLUSIONS: The serum level of ROM was associated with CRP and DAS28-ESR, suggesting that ROM, in conjunction with CRP and MMP3, may be able to be used as a new biological disease marker to evaluate the disease activity of RA.

Entities:  

Keywords:  Disease activity; Oxidative stress; Reactive oxygen metabolites; Rheumatoid arthritis

Mesh:

Substances:

Year:  2014        PMID: 24670128     DOI: 10.3109/14397595.2014.891495

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  16 in total

1.  Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis.

Authors:  Maarten M Steinz; Malin Persson; Bejan Aresh; Karl Olsson; Arthur J Cheng; Emma Ahlstrand; Mats Lilja; Tommy R Lundberg; Eric Rullman; Kristina Ängeby Möller; Katalin Sandor; Sofia Ajeganova; Takashi Yamada; Nicole Beard; Björn Cg Karlsson; Pasi Tavi; Ellinor Kenne; Camilla I Svensson; Dilson E Rassier; Roger Karlsson; Ran Friedman; Thomas Gustafsson; Johanna T Lanner
Journal:  JCI Insight       Date:  2019-03-28

Review 2.  Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis.

Authors:  Neide Tomimura Costa; Tatiana Mayumi Veiga Iriyoda; Daniela Frizon Alfieri; Andréa Name Colado Simão; Isaias Dichi
Journal:  Inflammopharmacology       Date:  2018-07-30       Impact factor: 4.473

3.  Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.

Authors:  Arata Nakajima; Yasuchika Aoki; Masato Sonobe; Hiroshi Takahashi; Masahiko Saito; Koichi Nakagawa
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

4.  Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.

Authors:  Neide Tomimura Costa; Bruna Miglioranza Scavuzzi; Tatiana Mayumi Veiga Iriyoda; Marcell Alysson Batisti Lozovoy; Daniela Frizon Alfieri; Fabiano Aparecido de Medeiros; Marcelo Cândido de Sá; Pâmela Lonardoni Micheletti; Bruno Alexandre Sekiguchi; Edna Maria Vissoci Reiche; Michael Maes; Andréa Name Colado Simão; Isaias Dichi
Journal:  Clin Exp Med       Date:  2018-04-11       Impact factor: 3.984

5.  Integrated Serum and Fecal Metabolomics Study of Collagen-Induced Arthritis Rats and the Therapeutic Effects of the Zushima Tablet.

Authors:  Jinjun Shan; Linxiu Peng; Wenjuan Qian; Tong Xie; An Kang; Bei Gao; Liuqing Di
Journal:  Front Pharmacol       Date:  2018-08-14       Impact factor: 5.810

6.  Assessment of oxidative stress in autism spectrum disorder using reactive oxygen metabolites and biological antioxidant potential.

Authors:  Masahito Morimoto; Toshiaki Hashimoto; Yoshimi Tsuda; Tadanori Nakatsu; Taisuke Kitaoka; Shojiro Kyotani
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

Review 7.  Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review.

Authors:  Celia María Quiñonez-Flores; Susana Aideé González-Chávez; Danyella Del Río Nájera; César Pacheco-Tena
Journal:  Biomed Res Int       Date:  2016-05-31       Impact factor: 3.411

8.  Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.

Authors:  Neide Tomimura Costa; Tatiana Mayumi Veiga Iriyoda; Ana Paula Kallaur; Francieli Delongui; Daniela Frizon Alfieri; Marcell Alysson Batisti Lozovoy; Ricardo Braga Amin; Vinicius Daher Alvares Delfino; Isaias Dichi; Andréa Name Colado Simão
Journal:  Oxid Med Cell Longev       Date:  2016-05-31       Impact factor: 6.543

9.  Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Authors:  Uta Hardt; Anders Larsson; Iva Gunnarsson; Robert M Clancy; Michelle Petri; Jill P Buyon; Gregg J Silverman; Elisabet Svenungsson; Caroline Grönwall
Journal:  Arthritis Res Ther       Date:  2018-02-26       Impact factor: 5.156

10.  Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis.

Authors:  Arata Nakajima; Keiichiro Terayama; Masato Sonobe; Yasuchika Aoki; Hiroshi Takahashi; Yorikazu Akatsu; Junya Saito; Shinji Taniguchi; Manabu Yamada; Ayako Kubota; Koichi Nakagawa
Journal:  BMC Rheumatol       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.